Page last updated: 2024-10-22

anthralin and Bardet-Biedl Syndrome

anthralin has been researched along with Bardet-Biedl Syndrome in 1 studies

Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.

Bardet-Biedl Syndrome: An autosomal recessive disorder characterized by RETINITIS PIGMENTOSA; POLYDACTYLY; OBESITY; MENTAL RETARDATION; hypogenitalism; renal dysplasia; and short stature. This syndrome has been distinguished as a separate entity from LAURENCE-MOON SYNDROME. (From J Med Genet 1997 Feb;34(2):92-8)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Margolin, L1
Haliulin, Y1

Other Studies

1 other study available for anthralin and Bardet-Biedl Syndrome

ArticleYear
Recalcitrant psoriasis vulgaris associated with Laurence-Moon-Biedl syndrome.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2003, Volume: 17, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Anthralin; Bardet-Biedl Syndrome; Drug Resistance, Multiple; Drug Th

2003